Trial Details

RECRUITING
Basic Information
Clinical ID c1352
Identifier NCT04183608
Trial Title A Trial COmparing staNdard of Care Versus Treat to Target With telemonitoRing and Patient Education in Patients With Ulcerative cOlitis Initiating Adalimumab
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Ulcerative Colitis
Interventions DRUG: Adalimumab|DIAGNOSTIC_TEST: Calprotectin|OTHER: e-Monitoring|OTHER: Therapy Education
Participant Information
Sponsor Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
City Cholet
Country/Region France
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE4
Time Information
Start Date 2020-01-14
Primary Completion Date 2025-04-25
Completion Date 2025-05-28